Clinical Trial Highlights

• Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial
• Consolidation with Arsenic Trioxide Significantly Improves Event-free Survival and Overall Survival among Patients with Newly Diagnosed Acute Promyelocytic Leukemia
• A Randomized, Controlled, Double-Blind Phase 3 Study of Bevacizumab/Interferon-α2a vs Placebo/Interferon- α2a as First-line Therapy in Metastatic Renal Cell Carcinoma
• Prophylactic Cranial Irradiation in Extensive Disease Small Cell Lung Cancer
• Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases
• Results of the EXTREME Study